KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 83 filers reported holding KEROS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,855,065 | -34.3% | 58,189 | -17.2% | 0.01% | -31.2% |
| Q2 2023 | $2,822,886 | +4.9% | 70,256 | +11.5% | 0.02% | -11.1% |
| Q1 2023 | $2,691,424 | -14.8% | 63,031 | -4.2% | 0.02% | -30.8% |
| Q4 2022 | $3,160,484 | +46.6% | 65,816 | +14.9% | 0.03% | +13.0% |
| Q3 2022 | $2,156,000 | +108.9% | 57,297 | +53.4% | 0.02% | +155.6% |
| Q2 2022 | $1,032,000 | -44.6% | 37,361 | +9.0% | 0.01% | -18.2% |
| Q1 2022 | $1,864,000 | -13.4% | 34,269 | -6.9% | 0.01% | 0.0% |
| Q4 2021 | $2,153,000 | +123.6% | 36,805 | +51.2% | 0.01% | +57.1% |
| Q3 2021 | $963,000 | -10.5% | 24,346 | -3.9% | 0.01% | 0.0% |
| Q2 2021 | $1,076,000 | -48.6% | 25,346 | -25.5% | 0.01% | -50.0% |
| Q1 2021 | $2,095,000 | +865.4% | 34,031 | +1004.9% | 0.01% | +600.0% |
| Q4 2020 | $217,000 | – | 3,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |